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IKs channels open in response to depolarization of the membrane
voltage during the cardiac action potential, passing potassium ions
outward to repolarize ventricular myocytes and end each beat. Here,
we show that the voltage required to activate IKs channels depends
on their covalent modification by small ubiquitin-like modifier
(SUMO) proteins. IKs channels are comprised of four KCNQ1 pore-
forming subunits, two KCNE1 accessory subunits, and up to four
SUMOs, one on Lys424 of each KCNQ1 subunit. Each SUMO shifts
the half-maximal activation voltage (V1/2) of IKs ∼ +8 mV, producing
a maximal +34-mV shift in neonatal mouse cardiac myocytes or Chi-
nese hamster ovary (CHO) cells expressing the mouse or human
subunits. Unexpectedly, channels formed without KCNE1 carry at
most two SUMOs despite having four available KCNQ1-Lys424 sites.
SUMOylation of KCNQ1 is KCNE1 dependent and determines the
native attributes of cardiac IKs in vivo.
KCNE1 | minK | KCNQ1 | KvLQT1 | heart
Cardiac IKs channels pass the slow component of the delayedrectifier potassium current that is necessary to produce normal
heart rate and rhythm. Thus, IKs varies in magnitude and timing
subject to neuronal and hormonal influences (1). Abnormal changes
in IKs function, due to inherited mutations in KCNQ1 or KCNE1, or
suppression of the current by medications, can produce long QT
syndrome (LQTS) and life-threatening cardiac arrhythmias (2).
KCNQ1 (also called KV7.1 and previously KVLQT) is a classical
voltage-gated potassium α-subunit with six transmembrane seg-
ments and a single pore-forming P loop. Human KCNQ1 has
variants up to 676 residues in length, whereas KCNE1 (minK) has
just 129 residues and a single transmembrane span (Fig. 1A). De-
spite its small size, KCNE1 is essential to the operation of IKs.
Compared with channels formed by KCNQ1 subunits alone,
KCNE1 produces a right shift in the half-maximal voltage required
to activate the channel (V1/2), slows the kinetics of activation and
deactivation, increases the channel unitary conductance, alters the
ion selectivity of the conduction pore and, modifies its pharma-
cology (3–8). KCNE1 also endows IKs channel with a high affinity
for PIP2 (9) and allows responsiveness to PKA-mediated phos-
phorylation following β-adrenergic stimulation (10). Here, we
demonstrate that the V1/2 inherent to native cardiac IKs channels
results from, and is modified by, KCNE1-dependent SUMOylation
of KCNQ1.
SUMOylation is the enzyme-mediated linkage of one of three
SUMO isoforms to the e-amino group of specific Lys residues on a
target protein (11). Present in all eukaryotic cells, the pathway was
recognized to regulate the activity of nuclear transcription factors
when we discovered it resident at the plasma membrane (12, 13)
and to regulate the excitability of cerebellar granule neurons via
SUMOylation of K2P1 and NaV1.2 (14, 15), and of hippocampal
neurons via modification of KV2.1 (16).
This study was inspired by the work of Qi et al. (17), who de-
scribe partial deficiency of the deSUMOylating enzyme SENP2 in
mice, showing it to produce seizures, bradycardia, and sudden
death, in association with decreased M-channel currents and in-
creased modification of KCNQ2 (KV7.2) subunits by SUMO2 in
the brain. Supporting a neurogenic basis for sudden cardiac death,
the authors report sinus pauses and AV conduction block following
seizure activity; because they also observe increased SUMOylation
of KCNQ1 in the brain by SUMO2, and others have shown that
mice carrying human LQTS mutations in KCNQ1 can develop
seizures and sudden death (18), we chose to study the effects of
SUMOylation of KCNQ1 in the heart on the operation of IKs.
To overcome the paucity of IKs in adult mouse heart, we used a
strategy for electrophysiology developed by others that allows study
of the current in neonatal cardiac ventricular myocytes (nCM) (19–
22). In nCM, we first used partial SENP2 knockdown and observed
that the conductance–voltage relationship of native cardiac IKs was
subject to tonic regulation by the SUMO pathway; the response was
then characterized directly by the acute intracellular application of
SUMO2 and SENP2. Reconstituting the channels in CHO cells
with mouse or human KCNQ1 and KCNE1 subunits allowed
identification of a single conserved SUMOylated residue—Lys424 in
human KCNQ1—that determined the basis for voltage dependence
of IKs channels. Total internal reflection fluorescent (TIRF) mi-
croscopy allowed counting of the number of KCNE1, KCNQ1, and
SUMO2 subunits in channel complexes, and with electrophysiology,
the effect of adding 1, 2, 3, and 4 SUMO2 monomers on the V1/2 of
IKs activation was shown to be linearly additive. Compared with
channels formed with only KCNQ1 subunits, KCNE1 incorporation
to create IKs channels shifts the V1/2 by +38 mV; SUMOylation of
all four sites in IKs channels yields an additional shift of +34 mV.
SUMOylation was not associated with changes in the surface den-
sity or the subunit stoichiometry of IKs channels.
Significance
The slow delayed rectifier K+ current (IKs) determines the length of
each human heartbeat because it activates after myocytes are
excited and depolarize. This sensitivity to voltage, as well as dy-
namic regulation by hormones and second messengers, underlies
the essential role of IKs in determining the duration and rhythm of
cardiac action potentials. Here, we demonstrate the unexpected
mechanism that establishes the voltage-dependent operation of IKs
channels: SUMOylation. When native IKs channels are resident in
the plasma membranes of neonatal mouse ventricular myocytes,
or human channels are reconstituted in CHO cells, each of the four
KCNQ1 pore-forming subunits is subject to monoSUMOylation in a
manner that depends on KCNE1 accessory subunits, leading to
stepwise depolarizing shifts in the activation voltage.
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Results
SUMO2 and SENP2 Regulate IKs in Neonatal Mouse Cardiac Ventricular
Myocytes. Whole-cell patch-clamp recording was used to study IKs
72 h after dissociation of nCM from the harvested heart. The re-
cording protocol was designed to isolate the slow component of the
delayed rectifier potassium current, as reported by others (19–23).
Briefly, a holding potential of −40 mV was used to inactivate the
voltage-gated Na+ channels and 1 μM isradipine was included in
the bath solution to block voltage-gated calcium channel currents.
Native IKs was defined per custom as the difference current isolated
by subtraction of the current measured in the presence of 30 μM
Chromanol-293B, a IKs inhibitor, from the current measured be-
fore application of the drug (23–26). All currents were evoked by
test pulses lasting 2 s from −60 to +60 mV in 20-mV increments,
followed by 2-s tail current pulses to −40 mV and interpulse in-
tervals of 15 s. The tail currents were used to assess isochronal
conductance-voltage relationships (iG-V) and current densities, the
latter after a step to +40 mV; biophysical parameters for nCM are
summarized in Table 1.
Native IKs in nCM was similar in appearance to the macroscopic,
Chromanol-293B–sensitive, time-dependent, slowly activating
delayed rectifier currents reported by others, including an apparent
V1/2 of ∼+10 mV (Fig. 1B) (19, 20, 27–29). nCM expressing a
scrambled shRNA and eGFP expressed from a lentivirus retained
parameters for IKs like those in wild-type cells. In contrast, nCM
expressing eGFP and shRNA directed to SENP2 showed a 51 ±
6% decrease in SENP2 mRNA by qPCR and a right shift in V1/2 to
28 ± 2 mV, decreased current density, slowed activation rates, and
faster deactivation kinetics (Fig. 1 C and D and Table 1). These
findings led us to hypothesize that partial knockdown of the
SENP2 mRNA level could regulate the voltage-dependent acti-
vation of native IKs. To confirm the hypothesis that the right shift in
the V1/2 was due to suppression of deSUMOylase activity and in-
creased SUMOylation, we introduced 1 nM SUMO2 into the cells
via the recording pipette, a manipulation that we have previously
shown to produce maximal SUMOylation of potassium channels in
central neurons or expressed heterologously in CHO cells (13, 16).
Currents evoked in the presence of 1 nM SUMO2 had a V1/2 of
26 ± 2 mV, and manifested current densities and gating kinetics
similar in magnitude to those observed in cells treated with
SENP2 shRNA. In contrast, addition of 1 nM SENP2 in the pi-
pette left-shifted the V1/2 to −3.3 ± 1.4 mV, increased the current
density, speeded the kinetics of activation, and slowed the time
course for deactivation. Of note, the Chromanol-293B–insensitive
potassium currents in the nCM (i.e., the non-IKs currents)
appeared to be unaltered by treatment with SENP2 shRNA or
scrambled shRNA, or by the inclusion of SUMO2 or SENP2 in the
pipette (Fig. S1).
SUMO2 Regulation of Human IKs in CHO Cells Requires KCNQ1 Lys424.
Based on our experience with other ion channels, we suspected
that SUMO2 regulation of IKs would result from direct modifi-
cation of the channel. To test this notion, we reconstituted the
channel by expression of human clone KCNQ1 and KCNE1
subunits in CHO cells and observed that the regulatory behaviors
seen in the nCM were recapitulated (Fig. 2). In accord with
expectations from our prior studies of IKs in CHO cells (30), IKs
channels with human subunits had a V1/2 of 25 ± 1.0 mV under
Fig. 1. SUMO regulates IKs in neonatal mouse cardiac ventricular myocytes.
nCM were identified by visualization of muscular striations and spontaneous
beating. IKs was isolated with 30 μM Chromanol-293B in the bath by the pro-
tocols described in the main text and Materials and Methods; biophysical pa-
rameters are in Table 1 as mean ± SEM for n = 6–11 cells. Currents measured
before application of Chromanol-293B and the Chromanol-293B–insensitive
current are shown in Fig. S1. (A) Subunit topology of KCNQ1 (black) and KCNE1
(green) show the expected stoichiometry. (B, Upper Left) nCM photomicro-
graph. (Scale bar: 50 μm.) (B, Lower Left) Representative family of currents for
native IKs. (B, Right) Representative isochronal conductance–voltage relation-
ships for native IKs with control solution in the pipette. (C) SENP2 mRNA level
measured by qPCR from groups of 5–10 eGFP-positive nCMs: untreated control
(black), SENP2-shRNA knockdown (SENP2 K.D., pink), and scramble-shRNA
(gray). SENP2-shRNA reduced the level of SENP2 mRNA by 51 ± 6%, com-
pared with the scramble-shRNA, (**P < 0.01). (D) iG-V relationships for native
IKs with control solution in the pipette as shown in B (black dash), 1 nM SENP2
(+SENP, blue), 1 nM SUMO2 (+SUMO, red), for nCM exposed to lentivirus
expressing shRNA for SENP2 knockdown (SENP2 K.D., pink) or a scramble
shRNA (scramble, gray).
Table 1. The SUMO pathway regulates IKs in neonatal mouse cardiac ventricular myocytes
Conditions V1/2, mV Current density, pA/pF τ activation, ms τ deactivation, ms Zδ
Control 10 ± 2 6.8 ± 0.4 583 ± 19 647 ± 32 15.1 ± 1.3
SENP2 in pipette −3.3 ± 1.4* 12 ± 0.7* 448 ± 13* 877 ± 27* 15.3 ± 1.2
SUMO2 in pipette 26 ± 2* 3.8 ± 0.3* 752 ± 18* 479 ± 14* 13.6 ± 1.6
shRNA SENP2 28 ± 2* 4.0 ± 0.2* 745 ± 14* 465 ± 15* 13.7 ± 2.2
shRNA scramble 14 ± 2 6.7 ± 0.3 594 ± 20 621 ± 19 15.1 ± 1.5
IKs studied in nCMs, as per Fig. 1. V1/2 and Zδ were determined from a Boltzmann function using tail current
densities at −40 mV. The tail current density was assessed by estimating the peak from a fit of the decay curve after
an activating pulse at +40 mV for 2 s. The τ for activation and deactivation was determined from a single expo-
nential fit in each experimental condition. Data are mean ± SEM with 6–11 cells. Lentivirus treated cells were
studied 48 h following infection. Currents measured before application of 30 μM Chromanol-293B, and the Chro-
manol-293–insensitive current are show in Fig. S1. Compared with the control condition, V1/2, current density, and τ
for activation and deactivation were significantly different with SENP2 or SUMO2 in the pipette, and when cells
were treated with shRNA SENP2 (unpaired t test, *P < 0.01), whereas there was no significant change from the
control when cells were treated with scrambled shRNA (unpaired t test, P > 0.05). Compared with the control
condition, the slope factor (Zδ) was not significantly different with SENP2, SUMO2, shRNA SENP2, and scrambled
shRNA (P > 0.05).
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control conditions; this was right-shifted to 42 ± 1 mV with
1 nM SUMO2 in the pipette and leftward to 7.6 ± 0.5 mV
with 1 nM SENP2, in concert with changed current density and
gating kinetics like those observed in the native cells (Table 2).
Of note, 1 nM SUMO1 had the same effect on IKs in CHO cells
as 1 nM SUMO2 (Table 2).
To identify potential SUMOylation site(s) in IKs channels we
analyzed the primary sequences of the subunits with an algorithm
Fig. 2. The SUMO pathway regulates human IKs in CHO cells. Human KCNQ1 and KCNE1 subunits were transfected into CHO cells, and whole-cell patch-clamp
recordings were performed 24–48 h afterward, as described by the protocols inMaterials and Methods. Biophysical parameters are in Table 2 (n = 6 cells, mean ±
SEM). (A, Upper) iG-V relationships (filled square) for wild-type human KCNQ1 and KCNE1 with 1 nM SENP2 (+SENP, blue), control solution (black), and 1 nM
SUMO2 (+SUMO, red). (A, Lower) Raw current traces for wild-type KCNQ1 and KCNE1 with 1 nM SENP2 (+SENP, blue), control solution (black), and 1 nM SUMO2
(+SUMO, red). (B, Upper) iG-V relationships for human KCNQ1-Lys424Gln and KCNE1 (open square) with 1 nM SENP2 (+SENP, blue), 1 nM SUMO2 (+SUMO, red),
and control solution (black). (B, Lower) Raw current traces for KCNQ1-Lys424Gln and KCNE1, with 1 nM SENP2 (+SENP, blue), control solution (black), and 1 nM
SUMO2 (+SUMO, red).
Table 2. SUMO regulates human IKs in CHO cells
Subunits Pipette solution V1/2, mV Current density, pA/pF τact, ms τdeact, ms Zδ
KCNE1 Control 25 ± 0.8 53 ± 6 510 ± 36 580 ± 49 17.9 ± 0.7
KCNQ1
KCNE1 SENP2 7.6 ± 0.5** 102 ± 6** 378 ± 34* 827 ± 36** 17.1 ± 0.4
KCNQ1
KCNE1 SUMO2 42 ± 1** 28 ± 2** 767 ± 13** 312 ± 33** 15.3 ± 1.2
KCNQ1
KCNE1 SUMO1 41 ± 2** 29 ± 1** 776 ± 20** 320 ± 22** 17.7 ± 1.6
KCNQ1
KCNE1 Control 7.8 ± 0.8** 97 ± 12** 370 ± 39* 833 ± 29** 17.9 ± 0.6
KCNQ1-Lys424Gln
KCNE1 SENP2 7.6 ± 1.1** 97 ± 13** 376 ± 49* 829 ± 48** 18.8 ± 0.8
KCNQ1-Lys424Gln
KCNE1 SUMO2 7.8 ± 1.6** 99 ± 11** 361 ± 37* 818 ± 35** 17.5 ± 0.6
KCNQ1-Lys424Gln
KCNQ1 Control −16 ± 1 6.0 ± 0.7 29 ± 2 230 ± 12 14.9 ± 1.1
KCNQ1 SENP2 −32 ± 1*** 9.2 ± 0.9*** 30 ± 1 231 ± 11 14.9 ± 0.8
KCNQ1 SUMO2 −14 ± 1 5.8 ± 0.8 28 ± 1 234 ± 12 15.7 ± 1.7
KCNQ1-Lys424Gln Control −31 ± 1*** 9.3 ± 0.6*** 30 ± 2 234 ± 11 14.9 ± 0.9
KCNQ1-Lys424Gln SENP2 −32 ± 1*** 9.8 ± 1.3*** 26 ± 3 241 ± 19 16.4 ± 1.0
KCNQ1-Lys424Gln SUMO2 −32 ± 2*** 9.6 ± 0.8*** 27 ± 2 237 ± 17 17.7 ± 1.4
Human KCNQ1 or KCNQ1-Lys424Gln expressed in CHO cells ± KCNE1 and studied as per Fig. 2 with control solution, 1 nM SUMO2,
1 nM SUMO1, or 1 nM SENP2 in the pipette as indicated. V1/2 and Zδ were determined from a Boltzmann function using tail current
densities; tail current density was assessed by estimating the peak from a fit of the decay curve after an activating pulse at +40 mV for
2 s, and the τ for activation and deactivation was determined from a single exponential fit. Data are mean ± SEM for 6–11 cells studied
from each condition. Compared with KCNQ1 + KCNE1 (with control pipette solution), V1/2, tail current density, τ for activation, and
deactivation were significantly different for SENP2-, SUMO2-, and SUMO1-treated conditions and also for KCNQ1-Lys424Gln + KCNE1
(with control pipette solution, SENP2, and SUMO2), unpaired t test, *P < 0.05 and **P < 0.01; whereas, the slope factor (Zδ) was not
significantly different with SENP2, SUMO2, SUMO1, and KCNQ1-Lys424Gln + KCNE1 (P > 0.05). Compared with KCNQ1 (with control
pipette solution), V1/2 and tail current density were significantly different for SENP2-treated conditions and also for KCNQ1-Lys424Gln
(with control pipette solution, SENP2, and SUMO2), unpaired t test, ***P < 0.01, but τ for activation and deactivation was not
significantly different; V1/2, tail current density and τ for activation and deactivation were not significantly different for SUMO2-
treated conditions (P > 0.05); the slope factor (Zδ) was not significantly different with SENP2, SUMO2, and KCNQ1-Lys424Gln (with
control pipette solution, SENP2, and SUMO2), P > 0.05.
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(31). We found that mutating Lys424 to Gln in human KCNQ1
(KCNQ1-Lys424Gln), within the motif Phe-Lys-Leu-Asp (similar
to the canonical SUMO motif ψ-K-X-E/D), produced a channel
that was unresponsive to SUMO2 or SENP2, and that operated
like wild-type IKs treated with SENP2, that is, a channel without
linked SUMO2 (Fig. 2). Thus, IKs channels formed with KCNE1
and KCNQ1-Lys424Gln had a V1/2 of 7.8 ± 0.8, 7.8 ± 1.6, and 7.6 ±
1.1 mV, when studied under control conditions or with 1 nM
SUMO2 or 1 nM SENP2 in the pipette, respectively (Table 2). IKs
produced in CHO cells with mouse KCNQ1 and KCNE1 subunits
responded to SUMO2 and SENP2 like their human counterparts
and the analogous mutation in mouse KCNQ1 Lys423Gln, ablated
responsiveness to SUMO2 and SENP2, and yielded a channel that
operated like the SENP2-treated wild-type isoform (Fig. S2).
KCNQ1 Lys424 Is the Only Residue Modified by SUMO2 in IKs Channels.
To examine interactions between IKs channels and SUMO, we
measured FRET in live CHO cells between subunits tagged with
CFP and YFP, a strategy we have used to study the SUMOylation
of other ion channels (13–16). Measured here by the photo-
bleaching rate of the CFP donor, FRET reports on a separation of
less than 10 nm between FPs—consistent with a protein–protein
interaction (Fig. 3 A and B). Tagging wild-type KCNQ1 and
KCNQ1-Lys424Gln subunits with CFP did not alter their V1/2, gat-
ing kinetics, or responsiveness to SUMO2 (Fig. S3). Similarly, we
have previously demonstrated that tagging the N terminus of
SUMO with YFP did not alter its operation (13–16). FRET was
measured between IKs channels formed with KCNQ1-CFP and
YFP-SUMO2. The mean time constant for photobleaching (τ) of
22.5 ± 0.9 s was similar to the value for the interaction of KCNQ1-
CFP with the SUMO ligase YFP-Ubc9 (21.6 ± 1.0 s; Fig. 3C). In
contrast, KCNQ1-CFP showed τ of 10.4 ± 1.0 s with both YFP-
SUMO291—a variant lacking the terminal GG motif required for
covalent linkage—and free YFP (10.5 ± 0.8 s). Similarly, KCNQ1-
Lys424Gln-CFP did not show FRET with YFP-SUMO2, YFP-
SUMO291, free YFP, or YFP-Ubc9, the last meeting expectations
because we have previously shown that the SUMO ligase requires
its target Lys to bind stably to channel subunits. The lack of FRET
between YFP-SUMO2 and IKs channels formed by KCNQ1-
Lys424Gln-CFP argues that KCNE1 subunits are not SUMOylated.
IKs Channels Are Modified by SUMO2 Up to Four Times, Once on Each
KCNQ1 Lys424. To determine the stoichiometry of SUMOylation,
we counted the number of SUMO2 monomers on individual IKs
channels at the surface of live CHO cells using simultaneous, two-
color TIRF microscopy, and single-particle photobleaching (Fig. 4
and Table 3). We have previously shown that modification of
KCNQ1 with TagRFP-T (KCNQ1-RFP) does not alter the ex-
pression or the biophysical properties of IKs channels, and that
KCNQ1-RFP can be visualized at the cell surface with other
subunits tagged with mTFP1 without confounding spectral overlap
(30). KCNQ1-RFP and mTFP-SUMO2, in the presence of un-
labeled KCNE1, were observed together at the cell membrane
(Fig. 4A). In keeping with the known structure of complete
channels, KCNQ1-RFP showed up to four bleaching steps, in a
distribution expected (due to prebleaching and missed events) for
the uniform expression of tetrameric channel assemblies (Fig. 4A).
The bleaching analysis of SUMO2 shows up to four steps, con-
sistent with one monoSUMOylation event on each KCNQ1 sub-
unit (Fig. 4A).
As in our recent work (30), we observed no more than two
bleaching steps for KCNE1 subunits in individual IKs channels.
Here, with KCNE1-RFP and mTFP-SUMO2 studied in the pres-
ence of unlabeled KCNQ1, we observed up to two steps for
KCNE1 and up to four steps for SUMO2 (Fig. 4B). Based on the
statistical strategy of Hines to determine the number of required
particles and to estimate accuracy (32), we determine a 2:4 subunit
stoichiometry for KCNE1:SUMO in fully SUMOylated single IKs
channels with a confidence approaching 1 (Table 3). Of note,
channels formed with KCNQ1-Lys424Gln-RFP subunits, and thus
no SUMO, also had two mTFP-tagged KCNE1 subunits, in-
dicating that the SUMOylation status of KCNQ1 did not alter the
α:β subunit composition of IKs channels (Fig. S4 and Table S1).
Each SUMO2 in IKs Channels Has an Additive Effect on Voltage-Dependent
Activation. To assess the role of individual SUMO2 adducts, we
studied concatemeric IKs channels that linked together KCNQ1
and/or KCNQ1-Lys424Gln subunits (indicated for this experiment
here as Q1 and Q1*, respectively) to control the maximum number
of SUMO2 that could link to the channel (Fig. 5). Thus, KCNE1
was expressed with Q1*-RFP or Q1*-Q1*-RFP (no SUMO sites),
Q1*-Q1*-Q1-Q1*-RFP (one site), Q1-Q1*, or Q1*-Q1-RFP (two
sites); Q1-Q1-Q1*-Q1-RFP (three SUMO sites); Q1-Q1-RFP or
Q1-RFP (four sites). TIRF microscopy (TIRFM) analysis con-
firmed the enforced stoichiometry of SUMOylation (Tables S2 and
S3). Whole-cell recordings showed that each SUMO2 monomer
added into the IKs channels right-shifted the V1/2 by ∼+8.5 mV. This
graded response accounts for the total excursion in the V1/2 of
∼30 mV (4 × ∼7.5 mV) observed when native IKs channels in nCM
or IKs channels in CHO cells were studied in conditions expected to
fully SUMOylate (1 nM SUMO2 in the pipette) or completely
deSUMOylate (1 nM SENP2 in the pipette; Figs. 1 and 2). In
Fig. 3. FRET shows that KCNQ1 Lys424 is the only residue modified by SUMO2 in IKs channels. FRET was assessed in live CHO cells expressing CFP-tagged
human KCNQ1 and unlabeled KCNE1 by measuring the time constant (τ) for CFP-photobleaching (donor) in the presence of YFP-tagged subunits (acceptor)
and fitting with a single exponential. Data are mean τ ± SEM for 2–5 areas of the plasma membrane of 5–7 cells per group. Significant changes in τ compared
with free YFP are indicated below. (A) KCNQ1-CFP (cyan) and YFP-SUMO2 (yellow) reach the cell surface. The boxed area of membrane shows donor pho-
tobleaching with continuous illumination. (Scale bar: 20 μm.) (B) Exemplar photobleaching studies show the decay of fluorescence intensity for single cells
expressing YFP-SUMO2 and KCNQ1-CFP (filled) or KCNQ1-Lys424Gln-CFP (open) fit by a single exponential to give τ. (C) FRET shows assembly of KCNQ1-CFP
(black bars) when expressed with untagged KCNE1 with YFP-SUMO2 and YFP-Ubc9 (τ = 22.5 ± 0.9 and 21.6 ± 1.0, respectively; P < 0.001) but not with linkage-
incompetent YFP-SUMO291 or free YFP (τ = 10.4 ± 1.0 and 10.5 ± 0.8, respectively). In contrast, KCNQ1-Lys424Gln-CFP (open bars) did not show FRET with YFP-
SUMO2, YFP-SUMO291, YFP-Ubc9, or free YFP (τ = 10.0 ± 0.9; 11.0 ± 0.7; 10.8 ± 0.7; and 11.0 ± 0.8, respectively).
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addition to a change in the voltage required to activate the IKs
channels, SUMOylation also evokes graded changes in gating ki-
netics, slowing the time course for channel activation by ∼20% and
speeding deactivation by ∼20% per SUMO2 added into the com-
plex (Table S4). For each concatemer studied, the number of
SUMO2 monomers counted was equal to and not greater than the
number of Lys424 residues in the channel complex, arguing against
the formation of polySUMO2-chains. Analysis of the surface den-
sity of isolated and colocalized fluorescent particles revealed that
mTFP-SUMO2 was not observed at the plasma membrane of CHO
cells expressing KCNQ1-Lys424Gln-RFP subunits with KCNE1,
indicating that KCNE1 subunits are not SUMOylated (Table S5).
TIRFM was also used to show that although the current density
nearly doubles when IKs channels are formed with KCNE1 and
KCNQ1-Lys424Gln subunits compared with wild-type KCNE1 and
KCNQ1 subunits, the increase was not associated with a change in
the number of channels at the surface of live CHO cells (Table S6);
thus, SUMOylation did not alter the steady-state surface expres-
sion of IKs channels.
KCNE1 Determines the Valence of SUMOylation. Unexpectedly,
KCNQ1 channels, formed in the absence of KCNE1, were found
to carry only two SUMO2s (Fig. 6). Whole-cell voltage-clamp
recording of KCNQ1 channels with 1 nM SENP2 in the pipette
showed that deSUMOylation left shifted V1/2 to −32 ± 1 mV from
its control level of −16 ± 1 mV and increased the current-density.
With 1 nM SUMO2 in the pipette, the V1/2 and current density
remained unaltered, suggesting that KCNQ1 channels are maxi-
mally SUMOylated under control conditions (Fig. 6A). Channels
formed with KCNQ1-Lys424Gln showed no change with either
SUMO2 or SENP2 in the pipette, with biophysical parameters
similar to those observed for KCNQ1 channels studied with 1 nM
SENP2 in the recording pipette. Despite this difference from IKs
channels, FRET showed that the Lys424 site was still mediating
interaction with SUMO2 in a fashion that required covalent link-
age and allowed assembly with the SUMO ligase, Ubc9 (Fig. 6B).
In contrast to IKs channels (Fig. 4 and Fig. 5), TIRFM revealed that
KCNQ1 channels formed in the absence of KCNE1 were modified
at most by two SUMO2 subunits (Fig. 6C and Table 3).
Discussion
In this report, we demonstrate that SUMOylation regulates the
biophysical properties of IKs channels in cardiac myocytes as well as
channels formed by heterologous expression of the constituent
subunits in CHO cells. IKs channels can be SUMOylated up to four
times and this produces ∼34-mV right-shift in the V1/2 in nCM and
CHO cells; thus, SUMOylation decreases the magnitude of repo-
larizing current for a given membrane potential, an excitatory effect.
We show that IKs channels have five distinct SUMOylation states
and as the valence of SUMOylation increases from 0 to 4, the V1/2
of activation is right-shifted by ∼+8 mV per SUMO2, in a stepwise
manner. SUMOylation also evokes graded changes in the gating
kinetics of IKs channels, slowing the time course for channel acti-
vation by ∼20% and speeding deactivation by ∼20% per SUMO2
added into the complex (Table S4). TIRFM shows that the decrease
in current density with SUMOylation of IKs channels is not associ-
ated with a change in the number of channels at the surface of live
CHO cells (Table S6), suggesting that surface turnover of IKs
channels is not SUMO dependent under the conditions of this study.
Although the changes in voltage-dependent activation kinetics with
SUMOylation are thus sufficient to explain the decrease in current
density of IKs channels, our data do not exclude the possibility that
SUMOylation has small effects on the unitary conductance.
Whereas IKs carries up to four SUMOs, KCNQ1 channels
formed without KCNE1 carry a maximum of two SUMOs despite
having four Lys424 binding sites (Fig. 6); perhaps this is not sur-
prising because we observed KV2.1 channels in the absence of
accessory subunits are also tetramers that carry a maximum of two
Fig. 4. IKs channels are modified by SUMO2 up to four times. Single KCNQ1-RFP or KCNQ1-Lys424Gln-RFP subunits were expressed in CHO cells with unlabeled
KCNE1 and mTFP-SUMO2, or KCNE1-RFP, unlabeled KCNQ1, and mTFP-SUMO2 were expressed, as indicated, and studied by TIRFM, as described inMaterials and
Methods. Data represent 4–6 cells per condition, and single-particles statistical analyses are summarized in Table 3. (A, Upper) Exemplar single colocalized particles
(white, encircled) observed at the surface of cells expressing KCNQ1-RFP (faux red), untagged-KCNE1, and mTFP-SUMO2 (faux cyan). The montages show si-
multaneous photobleaching for RFP or mTFP in the particle indicated with continuous excitation and an image every fifth frame. (A, Lower) Photobleaching time
courses and histograms of photobleaching steps for colocalized particles show four KCNQ1 subunits in complexes (black) and four SUMO2 subunits in complexes
(red). (B, Upper) Exemplar single colocalized particles (white, encircled) observed at the surface of cells expressing KCNE1-RFP (faux red) and untagged-KCNQ1 and
mTFP-SUMO2 (faux cyan). The montages show simultaneous photobleaching for RFP or mTFP in the particle indicated with continuous excitation and an image
every fifth frame. (B, Lower) Photobleaching time courses and histograms of photobleaching steps for colocalized particles show two KCNE1 subunits in complexes
(green) and four SUMO2 subunits in complexes (red). (C) Cartoon presentation indicates stoichiometry: KCNQ1 subunits are black, KCNE1 subunits are green, and
SUMO2 subunits are red.
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SUMO monomers, on nonadjacent subunits (14). Because IKs can
accommodate up to four SUMO monomers, one per Lys424, the
incorporation of KCNE1 is surmised to expose either the Ubc9
binding site or the SUMO conjugation site on the two other sub-
units. Arguing against the proposal that highly SUMOylated
KCNQ1 channels are rapidly internalized in the absence of KCNE1,
we fail to detect channels with three or four SUMOs at the cell
surface in single-molecule photobleaching studies despite the time
resolution of our TIRF experiments (1 Hz) and the limited mobility
of the channels on the surface of the mammalian cells that we study
here at room temperature. It remains possible that if KCNQ1
channels are SUMOylated inside the cell, their transit to the surface
might be restricted.
A number of mechanisms might be in play to shift the iG-V re-
lationship of IKs channels. The shift in the V1/2 due to KCNE1 in the
absence of SUMOylation can be inferred by study of channels
formed by KCNQ1-Lys424Gln subunits and is estimated to be
∼+38 mV; our study of wild-type IKs channels shows SUMOylation
to produce an excursion of up to ∼+34 mV (Fig. 6D). Because
KCNE1 slows the movement of the voltage sensor domains (VSDs)
in KCNQ1 to produce the slow channel activation characteristic of
IKs (8, 33), SUMOylation might be anticipated to impact the ener-
getics of this conformation change. In addition, the coupling of VSD
movement and pore opening is subject to regulation, for example,
via PIP2 (34), and Lys424 resides between the A and B domains in
the intracellular C terminus of KCNQ1, a region associated with
regulation of IKs channel function by calmodulin, phospholipids and
kinases (35).
We observe macroscopic IKs current in nCM and CHO cells to
operate as if the channel population carries an average of two
SUMO2 monomers. This finding, and the observation that a de-
crease in SENP2 mRNA levels decreases IKs current in nCM,
support the conclusion that SUMOylation adjusts the biophysical
properties of IKs channels in the heart. Given that the biophysical
properties of native IKs channels vary subject to neuronal and hor-
monal influences (1), it is reasonable to posit that natural regulators
of IKs channels may operate via, or in concert with, the SUMO
pathway. Further, regulation of the SUMO pathway by acute stres-
sors is now well recognized in the CNS, as shown in our studies of
rapid hypoxic regulation of NaV1.2 in cerebellar granule neurons
(15), and it is therefore reasonable to expect it to act in a similar
manner on ion channels in the heart, such as IKs.
SUMOylation of IKs decreases the repolarizing current and is
thereby expected to prolong the duration of cardiac action potentials
in human where it is expressed in adult ventricular myocytes; sup-
pression of IKs is thus associated with a prolonged QT interval on the
surface electrocardiogram. Whereas we study neonatal mice where
IKs is prominent, in animals >6 wk of age the current declines to
undetectable levels in ventricular myocytes (10, 27), which may ex-
plain why Qi et al. (17) did not observe a prolonged QT or ventricular
arrhythmia with SENP2 knockdown in the adult mice they studied.
These authors (17) did observe bradycardia and atrioventricular
Table 3. Stoichiometry of SUMOylation of IKs
Subunits expressed
Analysis
KCNE1, KCNQ1-
RFP, and mTFP-
SUMO2
KCNE1-RFP,
KCNQ1, and
mTFP-SUMO2
No KCNE1,
KCNQ1-RFP,
and mTFP-
SUMO2
Determined
stoichiometry
SUMO:KCNQ1 KCNE1:SUMO SUMO:KCNQ1
4:4 2:4 2:4
Particles studied 50 52 52
Particles with SUMO KCNQ1 KCNE1 SUMO SUMO KCNQ1
One step 3 4 6 4 6 3
Two steps 10 7 46 9 46 8
Three steps 20 22 0 22 0 23
Four steps 17 17 0 17 0 18
Confidence 0.98 0.98 1 0.98 1 0.99
θ 0.76 0.76 0.95 0.75 0.95 0.77
θ + 1 0.6 0.61 0.63 0.6 0.63 0.62
FP-tagged KCNQ1, SUMO2, and KCNE1 subunits were expressed in CHO
cells and studied by TIRFM as described in Fig. 4. The number of photobleach-
ing steps observed for each fluorophore in each fluorescent spot reports on
the stoichiometry of the channel complex. KCNQ1 channels are tetramers and
show no more than four bleaching steps when tagged with RFP (Fig. 4). Study
of KCNQ1 colocalized with mTFP-SUMO2 and untagged KCNE1 reveals a
4:4 stoichiometry of KCNQ1 and SUMO2 in each IKs channel. The statistical
confidence in the null hypotheses that KCNQ1 forms tetramers and that four
SUMO2s assemble with each IKs channel complex was assessed to be greater
than 0.98. Prebleaching and variance in quantum efficiency reduce the prob-
ability of observing each possible bleaching event (θ). θ is calculated from the
value of n and the distribution of the photobleaching data per Hines (32) and
as before for IKs channels (30). θ is decreased when the distribution is altered to
estimate the possibility that higher numbers of missed bleaching steps, for
example θ + 1, indicating that this stoichiometry is less likely.
Fig. 5. Each SUMO2 in IKs channels has an additive effect on voltage-
dependent activation. KCNQ1 (indicated as Q1) or KCNQ1-Lys424Gln (Q1*)
subunits were linked to form RFP-tagged channels with fixed numbers of
SUMO binding sites and were expressed with mTFP-SUMO2 and untagged
KCNE1 in CHO cells and assessed for stoichiometry by TIRFM as per Fig. 4.
Whole-cell currents were recorded as per Fig. 2. SUMO2 (1 nM) was included in
the pipette solution to saturate all of the SUMObinding sites. Data represent 5–
6 cells per condition and biophysical parameters and single-particle statistical
analyses are summarized in Tables S1–S3. (Left) Expected SUMO2 stoichiometry
and symbols (filled black circle, Q1; open black circle with an asterisk, Q1*; filled
green circle, KCNE1; filled red circle, SUMO2) for indicated subunits. Photo-
bleaching histograms for SUMO2 particles and cartoons indicating determined
stoichiometry. (Upper Right) iG-V relationships for the eight channel types
studied. (Lower Right) Bar graph representation for the values of determined
half-maximal activation voltage for the eight channel types studied.
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(A-V) conduction block in adult mice with SENP2 knockdown that
was global or localized to the nervous system but not when it was
targeted to the heart; they hypothesize that increased CNS
SUMOylation can cause cardiac symptoms of neural origin as well
as seizures, and our findings with neonatal cardiac myocytes do not
contradict their conclusions.
The SUMO pathway has been shown to be active in slow pro-
cesses in the heart, including cardiac development, regulation of
metabolism, and disease progression (36). Thus, heart-specific
constitutive overexpression of SENP2 in mice has been associ-
ated with major congenital defects in both the atria and ventricles
of the heart (37). Whereas, chronic viral overexpression of
SUMO1 has been reported to have a positive role in treating heart
failure, improving cardiomyocyte intracellular calcium homeostasis
via effects on SERCA2A calcium pump activity in both a pressure
overload heart failure model in mice (38) and an ischemia heart
failure model in swine (39), inducible overexpression of SENP1 in
mice is reported to produce mitochondrial dysfunction in ventric-
ular myocytes and attributes resembling heart failure in humans
(40). That two manipulations that increase SUMOylation appear
to have opposite effects on the heart is likely to reflect the multi-
plicity of SUMO pathway targets, stimulus-dependent changes in
SUMOylation/deSUMOylation, chronic and acute changes over
time, and our nascent understanding of the SUMO pathway.
In addition to the data we present here on IKs, a growing body of
evidence indicates that SUMOylation regulates other cardiac ion
channels, including K2P1, KV2.1, KV1.5, and TRPM4, that were
studied in noncardiac tissues (or heterologous cells) but are natively
Fig. 6. In the absence of KCNE1, KCNQ1 channels carry only up to two SUMOs. KCNQ1 or KCNQ1-Lys424Gln channels were expressed in CHO cells without
KCNE1 and assessed for whole-cell currents with control, 1 nM SUMO2, or SENP2 in the pipette, as per Fig. 2; FRET, as per Fig. 3; and stoichiometry by TIRFM (as per
Fig. 4). Biophysical parameters and single-particle statistical analyses are summarized in Tables 2 and 3. (A, Left) iG-V relationships for wild-type human
KCNQ1 channels vary with 1 nM SENP2 (+SENP, blue), control solution (black), or 1 nM SUMO2 (+SUMO, red) in the pipette, showing V1/2 of −32 ± 1 mV, −16 ±
1mV, and −14 ± 2 mV, respectively, n = 5–6 cells each group. (A, Lower Left) Representative raw current traces for a cell with SENP2 (+SENP, blue), control solution
(black), or SUMO2 (+SUMO, red). (A, Right) iG-V relationships for human KCNQ1-Lys424Gln channels with 1 nM SENP2 (+SENP, blue), 1 nM SUMO2 (+SUMO, red),
and control solution (black) do not vary, showing V1/2 of −32 ± 1 mV, −32 ± 2 mV, and −31 ± 1 mV, respectively, n = 5–6 cells each group. (A, Lower Right)
Representative raw current traces for a cell with SENP2 (+SENP, blue), control solution (black), or SUMO2 (+SUMO, red). (B) FRET shows assembly of KCNQ1-CFP
(black bars) with YFP-SUMO2 and YFP-Ubc9 (τ = 22.7 ± 0.7 and 22.4 ± 0.4, respectively, P < 0.001) but not with linkage-incompetent YFP-SUMO291 or free YFP (τ =
10.4 ± 0.7 and 10.0 ± 0.6, respectively). In contrast, KCNQ1-Lys424Gln-CFP (open bars) did not show FRET with YFP-SUMO2, YFP-SUMO291, YFP-Ubc9, or free YFP
(τ = 10.7 ± 0.8, 9.9 ± 0.7, 10.5 ± 0.6, and 10.1 ± 0.6, respectively). (C) TIRFM photobleaching shows four KCNQ1 subunits and two SUMO2 subunits in each channel
complex. TIRFM single-particle statistical analysis is summarized in Table 3. (D) The cartoon indicates stoichiometry: KCNQ1 subunits are black, KCNE1 subunits are
green, and SUMO2 subunits are red. The effect of KCNE1 on V1/2 without SUMOylation, inferred from study of KCNQ1-Lys424Gln channels, and when wild-type IKs
channels carry four SUMO2 monomers.
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expressed in the heart (12, 14, 16, 41–43). Thus, KV1.5 and
KV2.1 are predominantly expressed in mouse atrial myocytes, where
they contribute to the slow-repolarizing current (44), and K2P1 and
TRPM4 are expressed in cardiac Purkinje fibers (45). A familial
missense mutation that increases SUMOylation of TRPM4 has
been associated with progressive A-V block (43). Thus, we expect
SUMOylation modulates cardiac physiology in a manner that varies
with localization of these SUMO-regulated proteins and activity of
SUMO pathway enzymes. As we have found in our studies of
central neurons, Xenopus oocytes, COS-7 cells, and CHO cells (12–
15), SUMO regulation of IKs in nCM suggests that SUMO pathway
enzymes will be found to be resident at the cardiac myocyte plasma
membrane and not restricted to the nucleus and cytosol.
Some years ago, we described the family of subunits related to
KCNE1, the mink-related peptides (46, 47), and KCNQ1 has since
been shown to assemble with all of them on heterologous expres-
sion. As reviewed by Abbott et al. (48), KCNQ1 has thus far been
demonstrated to assemble in vivo with KCNE1 in the heart and
inner ear; with KCNE2 in the stomach, thyroid, heart, and choroid
plexus; and with KCNE3 in breast, intestine, and airway epithelia.
Indeed, KCNQ1 has yet to be shown to operate in the body
without a KCNE subunit partner. Given that SUMO2 can modify
KCNQ1 subunits in the presence of KCNE1, it is reasonable to
assume that SUMO will regulate KCNQ1-containing channels with
these other KCNE subunits, because the SUMO pathway is
ubiquitous. In contrast, the Chromanol-293B–insensitive portion of
the delayed rectifier potassium current in nCM does not appear to
be regulated by the SUMO pathway. Although we did not identity
its basis, others report that HERG (KV11.1) passes the Chromanol-
293B–insensitive current in nCM (19, 20).
The stoichiometry of IKs channels has been an issue of debate
for some years. As we have previously observed (30, 49), IKs
channels studied here in CHO cells form with a fixed stoichiometry
of four KCNQ1 subunits and two KCNE1 subunits, a value cor-
roborated by some groups (50, 51) but not others (52). The data in
the current study further supports the conclusion that the subunit
composition of IKs channels does not vary with SUMOylation, and
KCNE1 is not SUMOylated (Fig. 4 and Table S5).
We focus here on SUMO2 following up on the findings of Qi
et al. (17) on M-current channels in the brain. In our hands,
SUMO1 in the pipette has the same effects as SUMO2 on IKs
channels in CHO cells. However, it is important to note that al-
though SUMO1 and SUMO2 share some targets, exchanging the
native cellular cytosol with pipette buffer containing 1 nM free
SUMO or SENP may not faithfully reflect the behavior of the reg-
ulators expressed from their genes at low natural levels found in vivo.
Materials and Methods
Molecular Biology and Reagents. Wild-type human KCNQ1 (NCBI ACC no.
NM_000218), human KCNE1 (NP_000210.2), mouse KCNQ1 (NCBI ACC no.
NM_008434), and mouse KCNE1 (NCBI ACC no. NM_008424) were handled in
pRAT, an in-house vector as previously described (8, 30). Human SUMO295 and
Ubc9 were amplified from a brain cDNA library (Clontech) and inserted into
pMAX. Point mutations were introduced by QuikChange mutagenesis (Agi-
lent). TagRFP-T (RFP), mTFP1 (TFP), YFP, and CFP genes were inserted in-frame
with the KCNQ1, KCNE1, SUMO2, or Ubc9 where noted, as before (15, 30).
SUMO2 and SENP2 were purchased from Boston Biochem. Isradipine and
Chromanol-293B were purchased from Sigma-Aldrich.
Neonatal Mouse Ventricular Myocyte Primary Culture. Neonatal ventricular
myocytes were cultured from mice. Briefly, postnatal day 1–3 CD-1 mouse
pups (Charles River) were decapitated and the ventricles were dissected, cut into
1-mm squares, and incubated with 0.15% Collagenase Type I (Worthington) in
calcium-free, magnesium-free HBSS for 1 h at 37 °C. The tissue was triturated
with a fire-polished Pasteur pipette, passed through a cell strainer (35 μm) to
remove extraneous debris, and plated onto 25-mm diameter glass coverslips
precoated with gelatin (0.1% in sterile water; ATCC). The cells are maintained in
DMEM (Thermo Fisher) supplemented with 10% horse serum (ATCC) and 5%
FBS (ATCC) and 1% penicillin and streptomycin (Thermo Fisher) at 5% CO2 and
37 °C for 72 h before experiments. Spontaneous beating and muscular striations
were used to identify cells in culture as myocytes.
SENP2 Lentiviral Particle Knock-Down Assay and qPCR Analysis. Lentiviral
particles expressing GFP and an shRNA targeting mouse SENP2 or a scrambled
control (OriGene Technologies) were applied to nCM for 12 h, where indicated.
Cells were studied for 48 h following infection and were identified visually by
the expression of GFP. Fluorescent cells (5–10 cells) were collected by glass
electrodes and analyzed with the Single-Cell-to-CT Kit (Thermo Fisher Scientific)
according to the manufacturer’s guidelines. In brief, the cells were lysed at
room temperature and reverse transcription was performed in a thermal cycler.
The products from reverse transcription were used for the real-time RT-PCR on
a Rotor-Gene Q cycler (QIAGEN) according to the manufacturer’s instructions.
TaqMan Gene Expression Assays were acquired from Thermo Fisher Scientific
for both SENP2 and GAPDH. All reactions were done in triplicates.
Cell Culture and Heterologous Expression. CHO-K1 cells (RRID: CVCL_0214) were
purchased fromATCC, identity authenticated by cytochrome c oxidase I analysis,
demonstrated to be mycoplasma free by Hoechst DNA stain and agar by cul-
ture, and maintained in F12K medium supplemented with 10% FBS (ATCC).
Plasmids were transfected into cells with Lipofectamine 2000 according to the
manufacturer’s instructions (Thermo Fisher). CHO cells for patch-clamp studies
were cotransfected with eGFP for experiments performed without FP-tagged
channel subunits. Experiments were performed 36–48 h posttransfection at
room temperature.
Whole-Cell Voltage-Clamp Electrophysiology. Whole-cell potassium currents
were recordedwith anAxopatch 200Bamplifier andpCLAMP software (Molecular
Devices) at filter and sampling rates of 2 and 10 kHz, respectively. CHO cells were
bathed in a solution comprising, inmM: 130NaCl, 4 KCl, 1.2MgCl2, 2 CaCl2, and 10
Hepes; pH was adjusted to 7.4 with NaOH. Recording electrodes were fabricated
from borosilicate glass (Warner) and fire polished to have a resistances of 2–4MΩ
when filled with a solution containing, inmM: 130 KCl, 1MgCl2, 5 EGTA, 5 K2ATP,
and 10 Hepes; pHwas adjusted to 7.4 with KOH. CHO cells had ameanwhole-cell
capacitance of 14 ± 0.6 pF; series resistance was typically <5 MΩ, and the voltage
error of <3 mV was not adjusted for. Cells for study were selected based on
fluorescence color (free eGFP in the absence of FP-tagged subunits). Currents
were evoked from CHO cells with 2-s test pulses from −120 to 80 mV from a
holding potential of −80 mV, with 20-mV increments. Tail currents were recorded
at −40 mV for 2 s. The interpulse interval was 15 s. Neonatal cardiac myocytes
were studied in a bath solution comprising, in mM: 132 NaCl, 4.8 KCl, 2 CaCl2, 1.2
MgCl2, 10 Hepes, 5 glucose, pH 7.4, with 1 μM isradipine to block voltage-gated
calcium channel currents. Pipettes were filled with a solution containing, in mM:
125 K-aspartate, 20 KCl, 10 EGTA, 10 ATP(Mg), and 10 Hepes, pH 7.3. nCM had a
mean whole-cell capacitance of 30 ± 3.57 pF; series resistance was typically <5
MΩ, the voltage error of <2.5 mV was not adjusted for. Currents were evoked
from nCM with 2-s test pulses from –60 to 60 mV from a holding potential of
–40 mV, with 20-mV increments. Tail currents were recorded at −40 mV for 2 s. IKs
was isolated by subtraction of the current measured in the presence of 30 μM
Chromanol-293B, a IKs inhibitor, from the current measured before application of
the drug. IKs-like currents were observed in ∼70% of nCM. Conductance (G)
was calculated from the tail currents and expressed as G/Gmax as a function of
the membrane voltage. G–V curves were obtained and fit to the equation
G=Gmax − 1=½1+ expððV −V1=2Þ=zδÞ as previously described (8, 30), where V is
the test potential, V1/2 is the voltage of half-maximal activation, and zδ is the
slope factor. Activation and deactivation kinetics were analyzed by fitting the
current traces with a single-exponential equation and are reported as τact and
τdeact, respectively. Current density was measured from fits of tail current decay
after an activating pulse of +40 mV lasting 2 s. All of the experiments were
performed at room temperature and all electrophysiological data were analyzed
in pCLAMP (Molecular Devices), Excel, and OriginLab software.
Live-Cell FRET Experiments and Analysis. FRET technique was used with live
CHO cells to evaluate and validate the direct protein-protein interaction be-
tween the SUMO protein and the KCNQ1 channel, which were heterologously
expressed at the cell surface. YFP-tagged SUMO2 and CFP-tagged KCNQ1 or
KCNQ1-Lys424Gln was transfected, with KCNE1 where indicated. The FRET
imaging data were collected using a fluorescence microscope (IX81; Olympus).
CFP and YFP were excited at 458 and 514 nm, respectively, and the emission
light was collected by bandpass filter of 470–500 nm and 525–575 nm, re-
spectively (14). Images were captured using a CCD camera controlled by
MetaMorph software (Molecular Devices) and analyzed with ImageJ.
TIRFM and Single-Particle Photobleaching. Single-protein particle complexes at
the surface of live CHO cells were identified and studied by TIRFM as previously
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described (15, 30). Briefly, the critical angle for TIRF was adjusted using a CellTIRF
illuminator (Olympus) and a high numerical-aperture Apochromat objective
(150×, 1.45 N.A.; Olympus) mounted on an automated fluorescence microscope
(IX81; Olympus), controlled by MetaMorph software (Molecular Devices). For
simultaneous illumination of two fluorophores, CellTIRF software (Olympus) was
used to adjust the critical angle for each excitation wavelength to generate
evanescent waves of equivalent depth (100 nm). A 561-nm laser line was used to
excite RFP, and a 445-nm laser line to excite mTFP. When mTFP was studied with
RFP simultaneously, emitted light signals were split by using a 520-nm dichroic
mirror mounted in a Dual View adapter (Photometrics), and each wavelength
was directed to one-half of a back-illuminated EM-CCD (Hamamatsu).
Analysis of Fluorescence Colocalization and Subunit Stoichiometry. Fluorophores
were photobleachedby continual excitation, and datawere captured asmovies
of 100–400 frames acquired at 1 Hz. When TFP was studied with RFP in the
same cell, the data for each fluorophore were saved as separate stacks and
processed in an identical manner. Misalignment of the data between stacks
was corrected in ImageJ using the StackReg plugin. Next, the degree of
colocalization between two fluorophores was determined by unbiased in-
tensity correlation analysis using the Coloc2 plugin to obtain the Manders’
coefficient for each cell. For stoichiometric analysis, fluorescent spots were
defined as a discrete 3 × 3 pixel region around a pixel of maximum intensity, as
before (15, 30). Fluorescence is reported as the change in fluorescence nor-
malized by the initial level of fluorescence for each trace. Statistical analyses to
assess the estimated confidence with which stoichiometry can be inferred from
the observed data and θ, the probability of successfully observing each possible
photobleaching event were performed in RStudio as described (15, 30). The
densities of colocalized and single fluorescent spots were determined fol-
lowing thresholding and watershed separation in ImageJ. Then, the particle
number was counted in four, separate 30 × 30 pixel regions of interest for five
cells per group using the Analyze plug-in.
Statistical Analysis. Statistical analyses (unpaired t tests) were performed on
biophysical parameters, cell surface density of fluorescent particles, and FRET
photobleaching time-constants data using pCLAMP (Molecular Devices), Excel
and OriginLab software and the statistical significance is indicated in table and
figure legends. The statistical significance of TIRF photobleaching parameters
was analyzed in RStudio, as before (15).
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